$InflaRx (IFRX.US)$ InflaRx (NASDAQ:IFRX) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.95) by 17.89 percent. This is unchanged from the same period last year. The company reported quarterly sales of $165.79 thousand which missed the analyst consensus estimate of $306.80 thousand by 45.96 percent. This is a 162.79 percent increase over sales of $63.09 thousand the same period last year

$InflaRx (IFRX.US)$ hmm gap to fill

$NanoVibronix (NAOV.US)$ Entering at 2.9 and exiting at 4.5 🔪